Shares of Aveanna Healthcare Holdings Inc (AVAH) recently rose above the average 12-month analyst target price of $2.64, currently trading at $2.76 per share. This movement prompts potential adjustments in analyst ratings, as five analysts contribute to the consensus, with targets ranging from $1.70 to $3.00 and a standard deviation of $0.54.
Analyst ratings for AVAH include one strong buy, five hold ratings, and two strong sells, resulting in an average rating of 3.25 on a 1 to 5 scale (1 being Strong Buy and 5 being Strong Sell). Investors are encouraged to reassess the stock, considering whether it may reach higher targets or if the valuation has become overstretched.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
